Home
Guidelines
Pathogens
Antimicrobials
Two weeks prior to splenectomy:
HiB⁽²⁾,
PCV‐13⁽²⁾⁽³⁾
Meningococcal conjugate vaccine⁽²⁾
Eight weeks following PCV‐13⁽²⁾⁽³⁾:
PPSV‐23⁽²⁾
Second dose of Meningococcal conjugate vaccine⁽²⁾
In five years:
Booster Meningococcal conjugate vaccine⁽²⁾ q5years
Booster PPSV‐23⁽²⁾
x 1
(1) Live attenuated vaccine (2) Inactive or component vaccine (3)
Only covered by MSP for certain indications
PPSV‐23: 23 valent pneumococcal polysaccharide vaccine PCV‐13: 13 valent pneumococcal conjugate vaccine